Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial. - Wikidata - awgldk - TriplyDB

Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.

Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.

http://www.wikidata.org/entity/Q35060161

about

Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis Risk factors and primary prevention trials for type 1 diabetes Immune therapy in type 1 diabetes mellitus Type 1 diabetes mellitus.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetes Type 1 diabetes: A predictable disease.Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes.Primary and secondary prevention of Type 1 diabetes Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.Targeting the trimolecular complex: the pathway towards type 1 diabetes prevention.Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.Non-antigenic and antigenic interventions in type 1 diabetes Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: relevance for type 1 diabetes.Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.Clinical application of regulatory T cells in type 1 diabetes.Altering the course of type 1 diabetes: an update on prevention and new-onset clinical trials.The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase.Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis.Can we prevent type 1 diabetes?Building and Validating a Prediction model for Pediatric Type 1 Diabetes Risk Using Next Generation Targeted Sequencing of Class II HLA Genes.Current and future efforts toward the prevention of type 1 diabetes.Optimization of current and future therapy for autoimmune diseases.Oral administration of carbonic anhydrase I ameliorates murine experimental colitis induced by Foxp3-CD4+CD25- T cells.Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes.Emerging Concepts on Disease-Modifying Therapies in Type 1 Diabetes.[Early diagnosis, early care--"Fr1da" screening of children for type 1 diabetes].In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research?Prevention: Nipped in the bud

P2860

Q26750714-59A97169-729B-4F27-8BCF-5BC02EC3F180 Q27005625-2C235160-004A-4BB9-8B22-E5CAC11FEA25 Q28282846-F98CD211-AA43-40A0-B1D9-12A9B68BACEE Q30235021-595D3EBB-2564-4333-8E9B-6954EDF58171 Q34375578-5AAA0663-0ABE-4C08-9EE5-E95D184C3499 Q34604619-E10C5B22-C66B-4847-9A21-AC2C228597C2 Q35207904-B6EB36F9-03D7-48CC-9E0B-0D81D14DC9C1 Q35437721-B554F663-8F1E-4D30-8932-E4D597470A7E Q36117948-66E8A608-4CD6-4995-AD3F-8CC1EFEE346D Q36547636-D19F05A3-1570-4B04-AE10-1FE76A0DF7C3 Q36631971-F21AD3D8-CBA7-486E-BC0C-063FDB1E9B57 Q36824703-20F5BD02-CBDD-4CC9-8AC6-8FFF7C82579C Q36913132-713E7820-116B-4859-BD4E-1375909C7A04 Q36913149-33983698-B40B-4435-9756-54AFE88F458A Q36932173-94461821-55F3-47CD-984B-3B61F9BEDC7D Q36977725-A891FB65-ECA4-4070-A4B4-79EFB4324C07 Q37638227-DF3859E5-77CB-4840-8D2A-B4BB31A347AF Q38047405-D7250C72-93A4-4A5C-AD34-C2C025BF276B Q38063547-2BD3C60A-5B4B-4796-B3C1-6EDFAB3A986B Q38102783-490B19D9-1B44-4958-9BCC-2355B84903CB Q38114958-29A1C4E4-CACF-4FE5-92F0-0DCD81EFF69F Q38161439-7901A785-E02F-47DA-BD26-FC45CDADB286 Q38161556-D6037232-C548-4E8E-9090-258B20EA9F46 Q38536492-2233C603-86A9-47AA-87E5-22E3F1B6D258 Q38586895-50DDAE3C-CF7D-45F9-B71E-356EFF07F018 Q38650009-094E6DEB-1AD0-4B0B-BF6F-7D7A67A43B15 Q38842306-32864B0E-8759-45A3-BF9E-21A393F7B00B Q39666645-4773D34D-A56C-43CC-B7DC-8435F02DDAA2 Q44830927-5CA21B9A-BA1D-42BB-ADBC-83AC2F0356D7 Q45342213-7AA257DC-8B65-4B7A-BB62-2150DF674F7D Q46115645-87B9C79E-E213-4850-B427-FA0B8F86F793 Q46453590-CB3CAE76-D2C4-4F56-A42C-A656C822A00F Q50077957-ACD96C55-C064-4738-A8D6-393694D0D853 Q53804809-9733C4CA-6316-4F81-AF33-6677EA302276 Q57449103-F99AA7E6-4D4E-49A5-B4F3-0ADA5B805ADB Q74441455-E37D3867-2715-4646-919F-5B61AFAD3A6D

P2860

Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.

http://www.wikidata.org/entity/Q35060161

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Long-term outcome of individua ...... 1 (DPT-1) oral insulin trial.

@ast

Long-term outcome of individua ...... 1 (DPT-1) oral insulin trial.

@en

type

label

Long-term outcome of individua ...... 1 (DPT-1) oral insulin trial.

@ast

Long-term outcome of individua ...... 1 (DPT-1) oral insulin trial.

@en

prefLabel

Long-term outcome of individua ...... 1 (DPT-1) oral insulin trial.

@ast

Long-term outcome of individua ...... 1 (DPT-1) oral insulin trial.

@en

P1433

Q35060161-CED7EF3E-8AAC-4FE6-AEB9-63DBA98A87C1

P1476

Q35060161-D4EEF877-1560-41AD-BC5A-D6C8C31F2752

P2093

Q35060161-365B99FE-B1E3-4554-9E7D-3337CE7CF0C9

Q35060161-80D9D112-D49A-43C5-AF41-925F0DC6BA0B

Q35060161-860F564E-B0E9-4860-9509-7F74918B4B1D

Q35060161-EEF8F044-9111-4078-8089-57FB0B1204B8

Q35060161-F66429FB-7F7C-4F3D-9966-68BF2CAB38AB

P2860

Q35060161-0F1A2251-0E8B-4248-9290-0B69A85C9976

Q35060161-14FF90FE-0DAD-4323-8B63-60FE309176CD

Q35060161-1577EEAB-BA73-452C-9AF0-D1D5ED019BE1

Q35060161-15AD70EB-1607-46FC-8E61-10A5C2C5E506

Q35060161-27C7A6FF-3E37-449A-BFAE-4F2A06453EC5

Q35060161-4EA0ACE8-268C-4D18-8312-BB0E3E22F40D

Q35060161-51BA5A1B-AD00-4732-8AB5-1A1F54DA9DE6

Q35060161-5E1FDB87-FB0E-4942-AD33-C4E625B0E174

Q35060161-6D077294-6A00-4F16-8447-0497D30D91CE

Q35060161-6FD43661-7C0F-4187-BFA1-5DF8F83784E6

P304

Q35060161-53ED145D-939C-4242-B19C-D790A0C714F5

P31

Q35060161-4B367931-685B-449A-AB4B-E6367BB747B5

P356

Q35060161-F30109C2-FF34-4796-97DE-B3122B6E20DE

P407

Q35060161-FE7AD47C-1C61-4D91-A33E-985DEC5E604E

P433

Q35060161-9C509976-1905-4866-84F9-2A83F8044C94

P478

Q35060161-2BFBCF27-F837-48E8-9D3F-5DE910711CD2

P50

Q35060161-315ADF4A-FC3F-45D8-885B-C3C02184D076

Q35060161-ACC7D89E-5673-4853-9A99-1B06AD320324

P577

Q35060161-E16CA480-1DB4-43F1-B133-EBC2F49E3CAA

P5875

Q35060161-E0A90A86-57AF-45A5-A21D-7C3F62652726

P698

Q35060161-A1414BB6-A4EA-4E36-BCEB-E2E87FFDF1B0

P921

Q35060161-3A7A87B3-DA7E-43AC-8980-87ECC50A12A4

Q35060161-8538ADB2-7F71-47F2-86AD-C438393FC88D

P932

Q35060161-8E609261-A725-4D59-87D2-194C7C7E89C3

P356

P1433

P1476

Long-term outcome of individua ...... 1 (DPT-1) oral insulin trial.

@en

P2093

DPT-1 and TrialNet Study Groups

http://www.w3.org/2001/XMLSchema#string

David Cuthbertson

http://www.w3.org/2001/XMLSchema#string

Desmond A Schatz

http://www.w3.org/2001/XMLSchema#string

Holly Ruhlig

http://www.w3.org/2001/XMLSchema#string

Jeffrey P Krischer

http://www.w3.org/2001/XMLSchema#string

P2860

Regulating the immune response to transplants. a role for CD4+ regulatory cells?

Suppressor T cells--they're back and critical for regulation of autoimmunity!

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

Oral tolerance: therapeutic implications for autoimmune diseases.

Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

The long and winding road to understanding and conquering type 1 diabetes.

Antigen-specific immunotherapy of autoimmune and allergic diseases

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.

Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes.

P304

1585-1590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-0523

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51162921

http://www.w3.org/2001/XMLSchema#string

P698

21610124

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3120180

http://www.w3.org/2001/XMLSchema#string